senofilcon A with new UV blocker

DEVICE2 trials

Sponsors

Johnson & Johnson Vision Care, Inc.

Conditions

AmetropiaVisual Acuity

Unknown Phase

Clinical Evaluation of Approved and Investigational Contact Lenses Using New UV Additive

CompletedNCT02982018

Johnson & Johnson Vision Care, Inc.Visual Acuity

Start: 2016-10-01End: 2017-02-18Updated: 2018-07-19

The Effects of Contact Lenses With Experimental Dye on Visual Function

CompletedNCT03556579

Johnson & Johnson Vision Care, Inc.Ametropia

Start: 2018-05-15End: 2018-09-20Updated: 2019-11-18